InvestorsHub Logo
Followers 53
Posts 1776
Boards Moderated 0
Alias Born 03/22/2015

Re: WeeZuhl post# 339307

Wednesday, 07/22/2020 3:26:03 PM

Wednesday, July 22, 2020 3:26:03 PM

Post# of 401719

Nostrum paid Elite $1.2M for #4 IR opioids with annual sales worth hundreds of millions of dollars.







I still can't believe they're gone. Poof. After years of development and millions of dollars-- sold for pennies without any discussion. I make business and personal decisions the same way I make medical decisions. Step One is to analyze the risks & benefits. What was a bigger risk for our company? Our auditor called us a going concern because of lack of income and lack of access to capital. Our low, low share price makes our current capital access through LPC extremely dilutive. Elite shareholders have already seen their positions diluted by 2X. This company was and is desperate for any source of income, and Nasrat refuses to commercialise these highly-lucrative assets. And then he dumps them out the back door so his NJ pharma bro can come by and load them up.


After everything Elite has gone through at his direction, Nasrat decided the bigger risk for our company was being sued for perfectly legal behavior in a highly-regulated business. Who can help me understand this? For me, I can only see the APPEARANCE OF IMPROPRIETY.



Occam's razor: the simplest solution is most likely the right one.

Hanlon's razor: never attribute to malice that which is adequately explained by stupidity.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News